Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

NCT01015222 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Dasatinib
DRUG: Bevacizumab
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center